Last reviewed · How we verify

NCT03102528

Acute Kidney Injury Following Cardiac Surgery

Completed Last updated 29 August 2019
What this trial tests

trial testing No intervention in Acute Kidney Injury in 495 participants. Completed in 20 June 2016.

Timeline
1 November 2014
Primary endpoint
31 October 2015
20 June 2016

Quick facts

Lead sponsorUniversity of Giessen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment495
Start date1 November 2014
Primary completion31 October 2015
Estimated completion20 June 2016

Drugs / interventions tested

Conditions studied

Sponsor

University of Giessen

Who can join

Eligibility, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury (AKI) occurs in approximately one-third of patients undergoing cardiac surgery (CS), and represents one of the most significant negative predictors of patient outcome in this population. The investigators sought to examine the risk factors associated with the development of AKI and renal recovery in patients undergoing cardiac surgery at San Bortolo Hospital, Italy 2014-2015.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Use of minimally invasive surgery and therapies mitigating pulmonary arterial pressure and intraoperative blood loss may offer protection against cardiac surgery-associated acute kidney injury
    Husain-Syed F, Quattrone MG, Ferrari F, Bezerra P, et al · · 2020 · DOI 10.21203/rs.2.22397/v1

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

Other University of Giessen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03102528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing